Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1984 2
1990 1
1993 1
1995 2
1996 1
1997 5
1998 1
2003 1
2005 3
2006 4
2007 3
2008 3
2009 4
2010 6
2011 7
2012 10
2013 8
2014 3
2015 2
2016 2
2017 4
2018 8
2019 12
2020 13
2021 15
2022 11
2023 14
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.
Guglielmelli P, Lasho TL, Rotunno G, Mudireddy M, Mannarelli C, Nicolosi M, Pacilli A, Pardanani A, Rumi E, Rosti V, Hanson CA, Mannelli F, Ketterling RP, Gangat N, Rambaldi A, Passamonti F, Barosi G, Barbui T, Cazzola M, Vannucchi AM, Tefferi A. Guglielmelli P, et al. Among authors: mannelli f. J Clin Oncol. 2018 Feb 1;36(4):310-318. doi: 10.1200/JCO.2017.76.4886. Epub 2017 Dec 9. J Clin Oncol. 2018. PMID: 29226763 Free article.
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
Al-Ali HK, Griesshammer M, Foltz L, Palumbo GA, Martino B, Palandri F, Liberati AM, le Coutre P, García-Hernández C, Zaritskey A, Tavares R, Gupta V, Raanani P, Giraldo P, Hänel M, Damiani D, Sacha T, Bouard C, Paley C, Tiwari R, Mannelli F, Vannucchi AM. Al-Ali HK, et al. Among authors: mannelli f. Br J Haematol. 2020 Jun;189(5):888-903. doi: 10.1111/bjh.16462. Epub 2020 Feb 4. Br J Haematol. 2020. PMID: 32017044 Free article. Clinical Trial.
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
Tefferi A, Loscocco GG, Farrukh F, Szuber N, Mannelli F, Pardanani A, Hanson CA, Ketterling RP, De Stefano V, Carobbio A, Barbui T, Guglielmelli P, Gangat N, Vannucchi AM. Tefferi A, et al. Among authors: mannelli f. Am J Hematol. 2023 Dec;98(12):1829-1837. doi: 10.1002/ajh.27079. Epub 2023 Sep 4. Am J Hematol. 2023. PMID: 37665758
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms.
Calabresi L, Carretta C, Romagnoli S, Rotunno G, Parenti S, Bertesi M, Bartalucci N, Rontauroli S, Chiereghin C, Castellano S, Gentili G, Maccari C, Vanderwert F, Mannelli F, Della Porta M, Manfredini R, Vannucchi AM, Guglielmelli P. Calabresi L, et al. Among authors: mannelli f. Am J Hematol. 2023 Oct;98(10):1520-1531. doi: 10.1002/ajh.27013. Epub 2023 Jul 3. Am J Hematol. 2023. PMID: 37399248
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
Sordi B, Vanderwert F, Crupi F, Gesullo F, Zanotti R, Bonadonna P, Crosera L, Elena C, Fiorelli N, Ferrari J, Grifoni F, Sciumè M, Parente R, Triggiani M, Palterer B, Mecheri V, Almerigogna F, Santi R, Di Medio L, Brandi ML, Iorno ML, Ciardetti I, Bencini S, Annunziato F, Mannarelli C, Pieri L, Guglielmelli P, Mannelli F, Vannucchi AM. Sordi B, et al. Among authors: mannelli f. J Allergy Clin Immunol. 2023 Feb;151(2):485-493.e11. doi: 10.1016/j.jaci.2022.09.038. Epub 2022 Oct 27. J Allergy Clin Immunol. 2023. PMID: 36309122
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.
Coltro G, Sant'Antonio E, Palumbo GA, Mannelli F, De Stefano V, Ruggeri M, Elli EM, Zanotti R, Borsani O, Bertozzi I, Duminuco A, Betti S, Carli G, Cavalca F, Tanasi I, Rumi E, Randi ML, Garibaldi B, Loscocco GG, Guglielmelli P, Vannucchi AM. Coltro G, et al. Among authors: mannelli f. Cancer Med. 2023 Apr;12(7):8166-8171. doi: 10.1002/cam4.5618. Epub 2023 Jan 27. Cancer Med. 2023. PMID: 36708083 Free PMC article.
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.
Mannelli F, Crupi F, Zanotti R, Pagano L, Rapezzi D, Tanasi I, Criscuolo M, Bonifacio M, Fresa A, Guglielmelli P, Vannucchi AM. Mannelli F, et al. Ther Adv Hematol. 2023 Nov 2;14:20406207231205643. doi: 10.1177/20406207231205643. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37929078 Free PMC article.
A life-threatening ruxolitinib discontinuation syndrome.
Coltro G, Mannelli F, Guglielmelli P, Pacilli A, Bosi A, Vannucchi AM. Coltro G, et al. Among authors: mannelli f. Am J Hematol. 2017 Aug;92(8):833-838. doi: 10.1002/ajh.24775. Epub 2017 Jun 1. Am J Hematol. 2017. PMID: 28457008 Free article. No abstract available.
134 results